Delumper Market Analysis

Applications Segment Analysis

Delumper market from the pharmaceutical industry segment is projected to hold largest share of about 28% during the projected period. The growth of the segment in this market is due to delumpers being necessary for the pharmaceutical industry to minimize the size of excipients and active pharmaceutical ingredients (APIs) in medication formulations. The need for delumpers in the pharmaceutical business is being driven by the expanding need for novel medications and the growing emphasis on precision medicine. In 2022, the Centre for Drug Evaluation and Research (CDER) authorized 37 new medications. There is a significant variation in the quantity of new pharmaceutical goods that are approved each year. In 2016, there were just over 20 unique pharmaceuticals released, whereas in 2018, there were nearly 60 new products approved. 50 new medication approvals were made in 2021. Furthermore, delumpers can guarantee a uniform particle size, lowering the possibility of segregation and raising the standard of the finished product.

Shaft Processor Types Segment Analysis

The twin shaft processor segment is expected to hold 65% share of the global delumper market during the forecast period. Twin shaft processors are commonly employed in sectors where fine grinding and particle size reduction are essential, like chemical processing, mining, and pharmaceuticals. In the upcoming years, there will likely be a notable expansion in the twin shaft processor category due to the growing need for dependable and effective machinery in these sectors. To meet the changing needs of end users, manufacturers are also concentrating on creating sophisticated dual-shaft processors with enhanced features and capabilities, which is fuelling the segment's expansion.

Our in-depth analysis of the global market includes the following segments: